Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
RYS完成签到,获得积分10
1秒前
威武白凝发布了新的文献求助10
4秒前
大小罐子完成签到,获得积分10
8秒前
婉腾完成签到 ,获得积分10
8秒前
humorlife完成签到,获得积分10
9秒前
唐唐完成签到 ,获得积分10
11秒前
望北完成签到 ,获得积分10
12秒前
12秒前
bellapp完成签到 ,获得积分10
12秒前
lvsehx发布了新的文献求助10
14秒前
yudandan@CJLU完成签到,获得积分10
15秒前
15秒前
你好纠结伦完成签到,获得积分10
17秒前
hwezhu发布了新的文献求助10
18秒前
nihao2023发布了新的文献求助10
22秒前
左岸完成签到 ,获得积分10
27秒前
29秒前
明理迎曼完成签到,获得积分10
30秒前
35秒前
35秒前
37秒前
小南发布了新的文献求助10
39秒前
1111发布了新的文献求助10
45秒前
洧甜yr完成签到 ,获得积分10
46秒前
嘻嘻完成签到,获得积分10
47秒前
高高的巨人完成签到 ,获得积分10
49秒前
50秒前
51秒前
52秒前
52秒前
所所应助单纯的又菱采纳,获得10
54秒前
朱先生完成签到 ,获得积分10
54秒前
涂涂完成签到 ,获得积分10
54秒前
酷酷的库库关注了科研通微信公众号
55秒前
搜集达人应助威武白凝采纳,获得10
55秒前
橙子慢慢来完成签到,获得积分10
56秒前
56秒前
儒雅沛文发布了新的文献求助10
57秒前
小南发布了新的文献求助10
58秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3781213
求助须知:如何正确求助?哪些是违规求助? 3326688
关于积分的说明 10228085
捐赠科研通 3041776
什么是DOI,文献DOI怎么找? 1669591
邀请新用户注册赠送积分活动 799109
科研通“疑难数据库(出版商)”最低求助积分说明 758751